M&A Deal Summary |
|
---|---|
Date | 2022-01-09 |
Target | PreventionGenetics |
Sector | Life Science |
Buyer(s) | Exact Sciences |
Deal Type | Add-on Acquisition |
Deal Value | 190M USD |
Advisor(s) | Crosstree Capital Partners, Inc. (Financial) Winston & Strawn (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1995 |
Sector | Life Science |
Employees | 6,500 |
Revenue | 2.5B USD (2023) |
Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.
DEAL STATS | # |
---|---|
Overall | 8 of 8 |
Sector (Life Science) | 6 of 6 |
Type (Add-on Acquisition) | 7 of 7 |
State (Wisconsin) | 1 of 1 |
Country (United States) | 7 of 7 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-02-16 |
Ashion Analytics
Phoenix, Arizona, United States Ashion Analytics is a clinical genomics testing company dedicated to accelerating the use of genomic information to help doctors provide patients with the right treatment for their disease. Ashion Analytics LLC was founded in 2014 and is based in Phoenix, Arizona. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-02 |
Exact Sciences - DX GPS Prostate Cancer Business
Madison, Wisconsin, United States Exact Sciences's DX GPS Prostate Cancer Business is a broadly commercialized and clinically validated test available today across the urology community. Exact Sciences's DX GPS Prostate Cancer Business is based in Madison, Wisconsin. |
Sell | $100M |